Stoxx Europe 50
|
4 578,18
|
-7,48
|
-0,16 %
|
Analysen zu Stoxx Europe 50-Werten
| 01.02.24 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | Santander Buy | UBS AG | |
| 01.02.24 | ABB Market-Perform | Bernstein Research | |
| 01.02.24 | Shell Neutral | UBS AG | |
| 01.02.24 | Sanofi Buy | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | SAP Add | Baader Bank | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 01.02.24 | BNP Paribas Buy | UBS AG | |
| 01.02.24 | ABB Neutral | UBS AG | |
| 01.02.24 | ING Group Buy | UBS AG | |
| 01.02.24 | Enel Hold | Jefferies & Company Inc. | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | Santander Halten | DZ BANK | |
| 31.01.24 | Santander Sector Perform | RBC Capital Markets | |
| 31.01.24 | Allianz Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Santander Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG | |
| 31.01.24 | Diageo Outperform | Bernstein Research | |
| 31.01.24 | Diageo Sell | Deutsche Bank AG | |
| 31.01.24 | L'Oréal Sell | Deutsche Bank AG | |
| 31.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Santander Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Mercedes-Benz Group Outperform | RBC Capital Markets | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 31.01.24 | Diageo Hold | Jefferies & Company Inc. | |
| 30.01.24 | Sanofi Buy | UBS AG | |
| 30.01.24 | Roche Neutral | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | Diageo Overweight | Barclays Capital | |
| 30.01.24 | Diageo Neutral | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| BNP Paribas | 2 |
| ASML NV | 2 |
| BASF | 2 |
| Novo Nordisk | 2 |
| Airbus | 2 |
| Rolls-Royce | 1 |
| Münchener Rückversicherungs-Gesellschaft | 1 |
| SAFRAN | 1 |
| L'Oréal | 1 |
| Diageo | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.